• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Analysis of mutations in six Chinese families with autosomal dominant polycystic kidney disease.六个常染色体显性遗传性多囊肾病中国家系的突变分析
Am J Transl Res. 2020 Dec 15;12(12):8123-8136. eCollection 2020.
2
Bilineal inheritance of pathogenic PKD1 and PKD2 variants in a Czech family with autosomal dominant polycystic kidney disease - a case report.捷克一个常染色体显性多囊肾病家族中致病PKD1和PKD2变异的双系遗传——病例报告
BMC Nephrol. 2018 Jul 4;19(1):163. doi: 10.1186/s12882-018-0978-2.
3
Mutational Screening of PKD1 and PKD2 Genes in Iranian Population Diagnosed with Autosomal Dominant Polycystic Kidney Disease.对伊朗常染色体显性多囊肾病患者的PKD1和PKD2基因进行突变筛查。
Clin Lab. 2017 Jul 1;63(7):1261-1267. doi: 10.7754/Clin.Lab.2017.170209.
4
Analysis of gene mutations in PKD1/PKD2 by multiplex ligation-dependent probe amplification: some new findings.通过多重连接依赖探针扩增分析PKD1/PKD2基因的突变:一些新发现。
Ren Fail. 2015 Nov;37(10):366-71. doi: 10.3109/0886022X.2015.1088349. Epub 2015 Sep 18.
5
Mutational analysis in patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD): Identification of five mutations in the PKD1 gene.常染色体显性多囊肾病(ADPKD)患者的突变分析:PKD1 基因中的五个突变的鉴定。
Gene. 2018 Sep 10;671:28-35. doi: 10.1016/j.gene.2018.05.112. Epub 2018 Jun 1.
6
Identifying gene mutations of Chinese patients with polycystic kidney disease through targeted next-generation sequencing technology.通过靶向下一代测序技术鉴定中国多囊肾病患者的基因突变。
Mol Genet Genomic Med. 2019 Jun;7(6):e720. doi: 10.1002/mgg3.720. Epub 2019 May 6.
7
Identification of Three Novel Frameshift Mutations in the PKD1 Gene in Iranian Families with Autosomal Dominant Polycystic Kidney Disease Using Efficient Targeted Next-Generation Sequencing.利用高效靶向新一代测序技术鉴定伊朗常染色体显性多囊肾病家族中PKD1基因的三个新型移码突变
Kidney Blood Press Res. 2018;43(2):471-478. doi: 10.1159/000488471. Epub 2018 Mar 22.
8
A single-center analysis of genotype-phenotype characteristics of Chinese patients with autosomal dominant polycystic kidney disease by targeted exome sequencing.通过靶向外显子组测序对中国常染色体显性多囊肾病患者的基因型-表型特征进行的单中心分析。
Front Genet. 2022 Sep 15;13:934463. doi: 10.3389/fgene.2022.934463. eCollection 2022.
9
PKD1 and PKD2 mutations in Slovenian families with autosomal dominant polycystic kidney disease.斯洛文尼亚常染色体显性多囊肾病家族中的PKD1和PKD2突变
BMC Med Genet. 2006 Jan 23;7:6. doi: 10.1186/1471-2350-7-6.
10
[Genetic diagnosis and prenatal diagnosis of autosomal dominant polycystic kidney disease].常染色体显性遗传性多囊肾病的基因诊断与产前诊断
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2019 May 10;36(5):419-423. doi: 10.3760/cma.j.issn.1003-9406.2019.05.002.

本文引用的文献

1
Cardamonin retards progression of autosomal dominant polycystic kidney disease via inhibiting renal cyst growth and interstitial fibrosis.小豆蔻明通过抑制肾囊肿生长和间质纤维化来延缓常染色体显性多囊肾病的进展。
Pharmacol Res. 2020 May;155:104751. doi: 10.1016/j.phrs.2020.104751. Epub 2020 Mar 6.
2
Metalloproteinase PAPP-A regulation of IGF-1 contributes to polycystic kidney disease pathogenesis.金属蛋白酶 PAPP-A 对 IGF-1 的调节有助于多囊肾病的发病机制。
JCI Insight. 2020 Feb 27;5(4):135700. doi: 10.1172/jci.insight.135700.
3
ADPKD current management and ongoing trials.ADPKD 的现行治疗方法和正在进行的试验。
J Nephrol. 2020 Apr;33(2):223-237. doi: 10.1007/s40620-019-00679-y. Epub 2019 Dec 18.
4
Proliferative signaling by ERBB proteins and RAF/MEK/ERK effectors in polycystic kidney disease.ERBB 蛋白和 RAF/MEK/ERK 效应物在多囊肾病中的增殖信号转导。
Cell Signal. 2020 Mar;67:109497. doi: 10.1016/j.cellsig.2019.109497. Epub 2019 Dec 9.
5
The PI3K/Akt/mTOR pathway in polycystic kidney disease: A complex interaction with polycystins and primary cilium.多囊肾病中 PI3K/Akt/mTOR 通路:与多囊蛋白和初级纤毛的复杂相互作用。
Cell Signal. 2020 Feb;66:109468. doi: 10.1016/j.cellsig.2019.109468. Epub 2019 Nov 9.
6
Autosomal dominant polycystic kidney disease: updated perspectives.常染色体显性多囊肾病:最新观点
Ther Clin Risk Manag. 2019 Aug 26;15:1041-1052. doi: 10.2147/TCRM.S196244. eCollection 2019.
7
Polycystin-1 Inhibits Cell Proliferation through Phosphatase PP2A/B56.多囊蛋白-1 通过磷酸酯酶 PP2A/B56 抑制细胞增殖。
Biomed Res Int. 2019 Sep 19;2019:2582401. doi: 10.1155/2019/2582401. eCollection 2019.
8
Exome sequencing of Saudi Arabian patients with ADPKD.对沙特阿拉伯 ADPKD 患者进行外显子组测序。
Ren Fail. 2019 Nov;41(1):842-849. doi: 10.1080/0886022X.2019.1655453.
9
Role of PKR in the Inhibition of Proliferation and Translation by Polycystin-1.PKR 在多囊蛋白-1 抑制增殖和翻译中的作用。
Biomed Res Int. 2019 Jun 23;2019:5320747. doi: 10.1155/2019/5320747. eCollection 2019.
10
Management of autosomal-dominant polycystic kidney disease-state-of-the-art.常染色体显性多囊肾病的管理——最新进展
Clin Kidney J. 2018 Dec;11(Suppl 1):i2-i13. doi: 10.1093/ckj/sfy103. Epub 2018 Dec 17.

六个常染色体显性遗传性多囊肾病中国家系的突变分析

Analysis of mutations in six Chinese families with autosomal dominant polycystic kidney disease.

作者信息

Wang Hanlu, Dai Sen, Zhang Jianhui, Li Yi, Gan Yumian, Lu Tao, Zhu Yaobin, Wu Jiabin, Lin Ning, Tang Faqiang, Luo Jiewei

机构信息

Shengli Clinical Medical College of Fujian Medical University Fuzhou 350001, China.

Fujian Provincial Hospital Fuzhou 350001, China.

出版信息

Am J Transl Res. 2020 Dec 15;12(12):8123-8136. eCollection 2020.

PMID:33437386
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7791523/
Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is the common hereditary kidney disease, resulting from mutations in polycystic kidney disease 1 () and polycystic kidney disease 2 (). Clinical data and genetic features of six Chinese families including ADPKD patients were analyzed via Next generation sequencing (NGS), Sanger sequencing, and multiplex ligation-dependent probe amplification. In family A, the proband (II5) with polycystic kidney (PK), hypertension, left ventricular hypertrophy, and valvular heart disease exhibited a heterozygous nonsense mutation, c.5086C>T (p.Gln1696Ter), in (NM_001009944). In family B, the proband (II3) with PK, polycystic liver (PL), hypertension, hypertrophy of the left ventricle and septum, valvular heart disease, chronic kidney disease (CKD) stage 5, bilateral renal calculi, and right inguinal hernia exhibited a heterozygous missense mutation, c.6695T>C (p.Phe2232Ser), in . In family C, the proband (III1) with PK, PL, seminal vesicle cyst, hypertension, CKD stage 3, hypertrophy of the left ventricle and septum, and valvular heart disease harbored a heterozygous nonsense mutation, c.662T>G (p.Leu221Ter), in (NM_000297). In family D, the proband (III3) with PK, hypertension, and CKD stage 5 harbored a heterozygous missense mutation, c.8311G>A (p.Glu2771Lys), in . In family E, the proband (II1) with PK, PL, hypertension, and CKD stage 5 exhibited a heterozygous deletion mutation, exon15-22, in . In family F, the proband (II2) with PK, PL, CKD stage 3, hypertension, thickened interventricular septum, and valvular heart disease carried a heterozygous missense mutation, c.1649A>G (p.His550Arg), in . Thus, three novel mutation sites which are responsible for ADPKD were discovered in this study.

摘要

常染色体显性多囊肾病(ADPKD)是常见的遗传性肾病,由多囊肾病1(PKD1)和多囊肾病2(PKD2)的突变引起。通过下一代测序(NGS)、桑格测序和多重连接依赖探针扩增技术,对包括ADPKD患者在内的6个中国家庭的临床数据和遗传特征进行了分析。在A家族中,患有多囊肾(PK)、高血压、左心室肥厚和瓣膜性心脏病的先证者(II5)在PKD1(NM_001009944)中表现出杂合性无义突变,c.5086C>T(p.Gln1696Ter)。在B家族中,患有PK、多囊肝(PL)、高血压、左心室和室间隔肥厚、瓣膜性心脏病、慢性肾脏病(CKD)5期、双侧肾结石和右腹股沟疝的先证者(II3)在PKD1中表现出杂合性错义突变,c.6695T>C(p.Phe2232Ser)。在C家族中,患有PK、PL、精囊囊肿、高血压、CKD 3期、左心室和室间隔肥厚以及瓣膜性心脏病的先证者(III1)在PKD1(NM_000297)中存在杂合性无义突变,c.662T>G(p.Leu221Ter)。在D家族中,患有PK、高血压和CKD 5期的先证者(III3)在PKD1中存在杂合性错义突变,c.8311G>A(p.Glu2771Lys)。在E家族中,患有PK、PL、高血压和CKD 5期的先证者(II1)在PKD1中表现出杂合性缺失突变,外显子15 - 22。在F家族中,患有PK、PL、CKD 3期、高血压、室间隔增厚和瓣膜性心脏病的先证者(II2)在PKD1中携带杂合性错义突变,c.1649A>G(p.His550Arg)。因此,本研究发现了3个导致ADPKD的新突变位点。